Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor
Iranian Biomedical Journal · 01.03.2020 · 24 (2) · 81-88
DOI: 10.29252/ibj.24.2.81 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian Biomedical Journal, online erschienen am 01.03.2020. Verfasst von Mahmoud Hassani und 8 weiteren Autor:innen. Die Arbeit wurde bisher 26-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hassani, M., Taheri, F. H., Sharifzadeh, Z., Arashkia, A., Hadjati, J., Weerden, W. M. V., Abdoli, S., Modarressi, M. H., & Abolhassani, M. (2020). Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor. Iranian Biomedical Journal, 24(2), 81-88. https://doi.org/10.29252/ibj.24.2.81
Vancouver
Hassani M, Taheri FH, Sharifzadeh Z, Arashkia A, Hadjati J, Weerden WMV, et al. Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor. Iranian Biomedical Journal. 2020;24(2):81-88. doi:10.29252/ibj.24.2.81
BibTeX
@article{Hassani2020,
author = {Hassani, Mahmoud and Taheri, Fatemeh Hajari and Sharifzadeh, Zahra and Arashkia, Arash and Hadjati, Jamshid and Weerden, Wytske M. van and Abdoli, Shahriyar and Modarressi, Mohammad Hossein and Abolhassani, Mohsen},
title = {Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor},
journal = {Iranian Biomedical Journal},
year = {2020},
volume = {24},
number = {2},
pages = {81--88},
doi = {10.29252/ibj.24.2.81}
}
EUVIMED